|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2005-8-19
|
|
pubmed:abstractText |
The risk of hepatotoxicity associated with different highly active antiretroviral therapy (HAART) regimens (containing multiple-protease inhibitors, single-protease inhibitors or non nucleoside reverse transcriptase inhibitors) in HIV-HCV co-infected patients has not been fully assessed.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-10632283,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-11153671,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-11426070,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-11588504,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-11782588,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-11964530,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-12089658,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-14986279,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-15369508,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-15577540,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16018804-9677182
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1471-2334
|
|
pubmed:author |
pubmed-author:BellaDanieleD,
pubmed-author:CarosiGiampieroG,
pubmed-author:CasariSalvatoreS,
pubmed-author:Di PerriGiovanniG,
pubmed-author:EPOKA-MASTER Study Group,
pubmed-author:FiliceGaetanoG,
pubmed-author:LadisaNicolettaN,
pubmed-author:LapadulaGiuseppeG,
pubmed-author:Lo CaputoSergioS,
pubmed-author:MazzottaFrancescoF,
pubmed-author:MinoliLorenzoL,
pubmed-author:NelsonMarkM,
pubmed-author:PastoreGiuseppeG,
pubmed-author:PuotiMassimoM,
pubmed-author:Quiros-RoldanEugeniaE,
pubmed-author:SotgiuGiovanniG,
pubmed-author:TinelliCarmineC,
pubmed-author:TortiCarloC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
58
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16018804-Adult,
pubmed-meshheading:16018804-Alanine Transaminase,
pubmed-meshheading:16018804-Anti-HIV Agents,
pubmed-meshheading:16018804-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16018804-Aspartate Aminotransferases,
pubmed-meshheading:16018804-Cohort Studies,
pubmed-meshheading:16018804-Drug-Induced Liver Injury,
pubmed-meshheading:16018804-HIV Infections,
pubmed-meshheading:16018804-Hepatitis C,
pubmed-meshheading:16018804-Humans,
pubmed-meshheading:16018804-Incidence,
pubmed-meshheading:16018804-Italy,
pubmed-meshheading:16018804-Liver,
pubmed-meshheading:16018804-Liver Function Tests,
pubmed-meshheading:16018804-Middle Aged,
pubmed-meshheading:16018804-Proportional Hazards Models,
pubmed-meshheading:16018804-Retrospective Studies,
pubmed-meshheading:16018804-Risk Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.
|
|
pubmed:affiliation |
Istituto di Malattie Infettive e Tropicali, Università degli Studi di Brescia, P.le Spedali Civili 1, Brescia, Italy. torti.carlo@libero.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
